Related Experiment Video

Updated: Jul 8, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Hepatitis C virus (HCV) infection: a systemic disease

Antonio Craxì1, Giacomo Laffi, Anna Linda Zignego

  • 1GI & Liver Unit, DI.BI:M.I.S., Policlinico, University of Palermo, Palermo, Italy.

Molecular Aspects of Medicine
|January 8, 2008
PubMed

Insights

Hepatitis C virus (HCV) infection causes liver and extrahepatic diseases. This review focuses on HCV-related systemic diseases and extrahepatic manifestations, highlighting treatment challenges.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Hepatitis C virus (HCV) is a significant global health concern, affecting approximately 180 million people worldwide.
  • HCV is both hepatotropic and lymphotropic, leading to chronic hepatitis, cirrhosis, hepatocellular carcinoma, and extrahepatic diseases like lymphoma.
  • The association of HCV with hepatic and extrahepatic malignancies classifies it as a human cancer virus, underscoring the need to understand its pathogenesis.

Purpose of the Study:

  • To review the principal aspects of HCV-induced systemic disease.
  • To focus on the extrahepatic manifestations of Hepatitis C virus infection.
  • To discuss the challenges in managing HCV-related sequelae, particularly extrahepatic manifestations.

Main Methods:

  • Literature review of Hepatitis C virus (HCV) infection.
  • Analysis of HCV's role in hepatic and extrahepatic diseases.
  • Examination of current treatment strategies and therapeutic management.

Main Results:

  • HCV infection is linked to severe hepatic conditions like cirrhosis and cancer.
  • Extrahepatic manifestations, including mixed cryoglobulinemia and lymphoma, are significant sequelae of HCV infection.
  • The pathogenesis of HCV-related hepatic and extrahepatic diseases remains incompletely understood.

Conclusions:

  • HCV infection presents a complex challenge due to its diverse systemic and extrahepatic effects.
  • Optimizing the clinical and therapeutic management of HCV patients requires a thorough understanding of its pathogenesis.
  • Tailored, case-by-case therapeutic approaches are often necessary, especially for extrahepatic manifestations.

More Related Videos

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis10:23

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Published on: April 17, 2017

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...